×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| AAREY DRUGS & PHARMACEUTICALS | 1037.6 | 13.71 | 1022.08 | 0.48 | 223.0 | 53.5 |
| PHARMAIDS PHARMACEUTICALS LTD. | NA | NA | NA | NA | 204 | |
| BILCARE LTD. | NA | NA | NA | NA | 201 | 32.5 |
Aarey Drugs & Pharmaceuticals Ltd, with Security Code 524412, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 158.2 | 51.0 | 57.8 | 76.5 | 210.4 | 126.9 | 105.1 | 133.8 | 108.1 | 102.2 |
| Expenses | 160.4 | 49.6 | 56.0 | 73.8 | 211.8 | 125.7 | 101.4 | 131.6 | 110.1 | 100.5 |
| Operating Profit | -2.2 | 1.3 | 1.8 | 2.7 | -1.4 | 1.2 | 3.7 | 2.2 | -2.0 | 1.7 |
| OPM % | -1.38% | 2.63% | 3.19% | 3.54% | -0.68% | 0.93% | 3.54% | 1.65% | -1.85% | 1.67% |
| Other Income | 6.0 | 0.7 | 0.8 | 0.3 | 5.1 | 1.6 | 0.0 | 0.7 | 7.5 | 1.6 |
| Interest | 1.0 | 0.9 | 1.3 | 1.1 | 1.2 | 1.0 | 1.5 | 0.9 | 2.5 | 1.0 |
| Depreciation | 0.2 | 0.4 | 0.4 | 0.5 | 0.4 | 0.5 | 0.5 | 0.6 | 1.4 | 0.5 |
| Profit before tax | 2.1 | 0.7 | 1.0 | 1.5 | 2.1 | 1.3 | 1.7 | 1.4 | 1.6 | 1.7 |
| Tax % | -48.7% | 0% | -22% | -30.2% | 0.3% | 6.9% | 8.6% | -48.7% | -67.7% | 20.7% |
| Net Profit | 1.4 | 0.7 | 0.8 | 1.0 | 2.2 | 1.2 | 1.6 | 0.7 | 0.5 | 1.4 |
| EPS in Rs | 0.14 | 0.29 | 0.31 | 0.4 | 0.77 | 0.88 | 1.14 | 0.26 | 0.02 | 0.48 |
| Metrics | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 48.9 | 52.8 | 77.2 | 41.9 | 32.2 | 63.3 | 108.6 | 94.6 | 82.4 | 96.0 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Expenses | 48.7 | 52.7 | 79.2 | 42.0 | 32.8 | 64.3 | 108.3 | 94.3 | 81.5 | 95.1 |
| Financing Profit | 0.2 | 0.1 | -2.0 | -0.1 | -0.6 | -0.9 | 0.3 | 0.3 | 0.9 | 0.9 |
| Financing Margin % | 0.3% | 0.2% | -2.5% | -0.3% | -1.7% | -1.5% | 0.3% | 0.4% | 1.1% | 0.9% |
| Other Income | 0.1 | 0.1 | 2.4 | 0.7 | 1.0 | 1.1 | 0.3 | 0.8 | 0.8 | 0.8 |
| Depreciation | -0.61 | -2.24 | -6.28 | -2.19 | -2.19 | -2.23 | 0.42 | -3.47 | -3.61 | -3.69 |
| Profit before tax | 0.3 | 0.2 | 0.4 | 0.6 | 0.5 | 0.2 | 0.6 | 1.1 | 1.7 | 1.8 |
| Tax % | 0% | 0% | -79.1% | 0% | 0% | 0% | -93.7% | 0% | 0% | 0% |
| Net Profit | 0.3 | 0.2 | 0.1 | 0.6 | 0.5 | 0.2 | 0.0 | 1.1 | 1.7 | 1.8 |
| EPS in Rs | ||||||||||
| Gross NPA % | % | % | % | % | % | % | % | % | % | % |
| Net NPA % | % | % | % | % | % | % | % | % | % | % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 2% |
| 3 Years: | 4% |
| TTM: | 66% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | -6% |
| 3 Years: | -10% |
| TTM: | 71% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 24% |
| 3 Years: | 13% |
| 1 Year: | 7% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|